The award recognizes the significant research contributions by faculty, researchers/scientists and trainees toward advancing the field of medicine
Claire Bitner
Dr. Art Walaszek interviewed on WORT-FM
Art Walaszek, MD, joined WORT-FM to discuss new treatments for Alzheimer’s disease in advance of the Wisconsin Alzheimer’s Disease Research Center (ADRC) Fall Community Conversation, held September 21, 2023. Walaszek chatted with host Jan Miyasaki …
Dr. Sterling Johnson joins in-depth discussion of Alzheimer’s disease research on WPR
Sterling Johnson, PhD, recently joined host Emily Auerbach for an in-depth discussion about Alzheimer’s disease research on The Ideas Network of Wisconsin Public Radio (WPR). Johnson discussed strategies to prevent Alzheimer’s disease, exciting therapies and …
UW–Madison Alzheimer’s disease researchers gather in Amsterdam at international conference
Badgers joined with tulips this July, as more than 50 Alzheimer’s disease experts from the University of Wisconsin–Madison presented at the 2023 Alzheimer’s Association International Conference (AAIC) in Amsterdam, Netherlands. The annual event is the world’s largest forum for dementia research and this year hosted 7,000 in-person attendees for a hybrid event held July 16–20, 2023.
‘We’re offering hope to our communities,’ Dr. Sterling Johnson says in interview with Wausau television news station
In an interview with a Wausau television news station, Sterling Johnson, Phd, described how a recent renewal grant from National Institutes of Health (NIH) supports avenues for more strides in research. The funding provides $35 …
Dr. Art Walaszek appointed chair of American Psychiatric Association council
Art Walazek, MD, has been appointed chair of the American Psychiatric Association (APA) Council on Medical Education & Lifelong Learning. Dr. Walaszek is education and public health leader of Wisconsin Alzheimer’s Institute.
Que Pasa Wisconsin: Dr. Maria Mora Pinzon shares information about lecanemab on Telemundo Wisconsin
Dr. Mora Pinzon spoke to Telemundo Wisconsin about the of Alzheimer’s disease treatment ‘Leqembi’ (lecanemab) on July 14, 2023. The medication was fully approved by the U.S. Food and Drug Administration (FDA) approved on July 6, 2023.
Dr. Cynthia Carlsson discusses FDA approval of Alzheimer’s drug lecanemab
Dr. Carlsson spoke to multiple media outlets about lecanemab and its use in the AHEAD study at UW.
WRAP study receives $35 million renewal grant
The new funding will also enable expansion of the project to identify other causes of cognitive decline and enhance the diversity of the cohort through recruitment of people from communities historically under-represented in research.
Dr. Maria Mora Pinzon named 2023 NIA IMPACT Faculty Scholar
Maria Mora Pinzon, MD, MS, FACPM, has been named a 2023 faculty scholar with the NIA IMPACT Collaboratory. Dr. Mora Pinzon has been appointed to the Stakeholder Engagement Team (SET) for a one-year term through …